Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsushi Kitani

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Current Protocols in Immunology|November 6, 2010
Efficient in vivo delivery of plasmids and oligonucleotides using hemagglutinating virus of Japan envelope (HVJ-E) vector in immunological disease modelsAtsushi Kitani, Stefan Fichtner-Feigl
Frontiers in Immunology|April 27, 2026
Immunological analysis of Blau syndrome, a unique autoinflammatory stateAtika Dhar, Atsushi Kitani, Warren Strober
Immunity|March 22, 2003
GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-betTakashi Usui, Ryuta Nishikomori, Atsushi Kitani, et al.
Annals of the New York Academy of Sciences|February 1, 2005
Insights into the mechanism of oral tolerance derived from the study of models of mucosal inflammationWarren Strober, Ivan Fuss, Monica Boirivant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-betaLili Xu, Atsushi Kitani, Ivan Fuss, et al.
Journal of Gastroenterology|April 18, 2003
Recent advances in the understanding of the induction and regulation of mucosal inflammationWarren Strober, Ivan J Fuss, Kazuhiko Nakamura, et al.
Nature Reviews. Immunology|February 24, 2006
Signalling pathways and molecular interactions of NOD1 and NOD2Warren Strober, Peter J Murray, Atsushi Kitani, et al.
Nature Immunology|June 29, 2004
NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responsesTomohiro Watanabe, Atsushi Kitani, Peter J Murray, et al.
Frontiers in Immunology|November 21, 2018
The Role of NLRP3 and IL-1β in the Pathogenesis of Inflammatory Bowel DiseaseLiming Mao, Atsushi Kitani, Warren Strober, et al.
Current Molecular Medicine|August 20, 2009
The signaling function of the IL-13Ralpha2 receptor in the development of gastrointestinal fibrosis and cancer surveillanceWarren Strober, Atsushi Kitani, Stefan Fichtner-Feigl, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Current Protocols in Immunology|November 6, 2010
Efficient in vivo delivery of plasmids and oligonucleotides using hemagglutinating virus of Japan envelope (HVJ-E) vector in immunological disease modelsAtsushi Kitani, Stefan Fichtner-Feigl
Frontiers in Immunology|April 27, 2026
Immunological analysis of Blau syndrome, a unique autoinflammatory stateAtika Dhar, Atsushi Kitani, Warren Strober
Immunity|March 22, 2003
GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-betTakashi Usui, Ryuta Nishikomori, Atsushi Kitani, et al.
Annals of the New York Academy of Sciences|February 1, 2005
Insights into the mechanism of oral tolerance derived from the study of models of mucosal inflammationWarren Strober, Ivan Fuss, Monica Boirivant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-betaLili Xu, Atsushi Kitani, Ivan Fuss, et al.
Journal of Gastroenterology|April 18, 2003
Recent advances in the understanding of the induction and regulation of mucosal inflammationWarren Strober, Ivan J Fuss, Kazuhiko Nakamura, et al.
Nature Reviews. Immunology|February 24, 2006
Signalling pathways and molecular interactions of NOD1 and NOD2Warren Strober, Peter J Murray, Atsushi Kitani, et al.
Nature Immunology|June 29, 2004
NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responsesTomohiro Watanabe, Atsushi Kitani, Peter J Murray, et al.
Frontiers in Immunology|November 21, 2018
The Role of NLRP3 and IL-1β in the Pathogenesis of Inflammatory Bowel DiseaseLiming Mao, Atsushi Kitani, Warren Strober, et al.
Current Molecular Medicine|August 20, 2009
The signaling function of the IL-13Ralpha2 receptor in the development of gastrointestinal fibrosis and cancer surveillanceWarren Strober, Atsushi Kitani, Stefan Fichtner-Feigl, et al.
Pageof 5